Davita Healthcare Partners Inc (DVA)
$153.73 -0.56 (-0.36%)Market Cap | 12.34B |
Revenue (ttm) | 12.82B |
Net Income (ttm) | 936.34M |
EPS (ttm) | N/A |
PE Ratio | 15.50 |
Forward PE | 14.11 |
Profit Margin | 7.31% |
Debt to Equity Ratio | 23.86 |
Volume | 882,474 |
Avg Vol | 978,186 |
Day's Range | N/A - N/A |
Shares Out | 80.00M |
Stochastic %K | 70% |
Beta | 1.04 |
Analysts | Sell |
Price Target | $169.14 |
Latest News on DVA


Mar 6, 2025, 10:00 AM EST - 4 weeks ago
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Feb 27, 2025, 9:00 AM EST - 5 weeks ago
YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 14, 2025, 1:01 PM EST - 6 weeks ago
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 8:16 AM EST - 6 weeks ago
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 13, 2025, 6:07 PM EST - 7 weeks ago
DaVita forecasts 2025 profit below estimates, shares plummet

Jan 30, 2025, 11:55 AM EST - 2 months ago
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 28, 2025, 2:39 PM EST - 2 months ago
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

Jan 15, 2025, 9:05 AM EST - 2 months ago
DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

Jan 9, 2025, 11:00 AM EST - 3 months ago
DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

Nov 14, 2024, 2:19 PM EST - 5 months ago
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 12, 2024, 9:05 AM EST - 5 months ago
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

Nov 8, 2024, 4:33 PM EST - 5 months ago
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

Oct 29, 2024, 4:23 PM EDT - 5 months ago
DaVita misses third-quarter profit estimates on higher costs

Oct 28, 2024, 11:05 AM EDT - 5 months ago
DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program

Oct 23, 2024, 10:00 AM EDT - 5 months ago
DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024

Oct 22, 2024, 8:00 AM EDT - 5 months ago
DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program

Oct 17, 2024, 1:00 PM EDT - 6 months ago
DaVita Appoints Jessica Hergenreter as Chief People Officer

Oct 11, 2024, 3:58 PM EDT - 6 months ago
DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton

Oct 9, 2024, 1:47 PM EDT - 6 months ago
DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

Oct 8, 2024, 1:38 PM EDT - 6 months ago
DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton

Sep 17, 2024, 9:00 AM EDT - 7 months ago
DaVita Accelerates Commitment to Community Health with Nationwide Tour

Sep 13, 2024, 8:00 AM EDT - 7 months ago
DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

Aug 20, 2024, 11:12 AM EDT - 8 months ago
DaVita: Scope For Valuation Upsides With Strengthening Economics (Rating Upgrade)

Aug 8, 2024, 5:34 PM EDT - 8 months ago
DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering


Jul 18, 2024, 2:00 PM EDT - 9 months ago
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

Jul 16, 2024, 10:20 AM EDT - 9 months ago
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research

May 14, 2024, 9:00 AM EDT - 11 months ago
DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report

May 9, 2024, 6:15 PM EDT - 11 months ago
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference

May 2, 2024, 5:32 PM EDT - 1 year ago
DaVita gains after upbeat quarterly profit prompts annual forecast raise

Apr 17, 2024, 7:31 PM EDT - 1 year ago
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call